Personalized PEEP and Prone Positioning in Severe ARDS
Official title: Assessment of the PEEP Responsiveness to Titrate End-expiratory Pressure and of the Need for Muscle Relaxation During Prone Positioning in Moderate-to-severe Acute Respiratory Distress Syndrome: A Master Protocol
Run by Assistance Publique - Hôpitaux de Paris · NCT06849570 · Data updated 2026-11-12
This trial tests whether tailoring PEEP levels and using prone positioning with or without muscle relaxation can improve outcomes for adults with severe ARDS in the ICU.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1200 (estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 29 sites (Aix-en-Provence and 28 other locations) |
| Status | Recruiting |
| Started | November 5, 2025 |
| Main results expected | November 5, 2028 |
| Study ends | November 5, 2029 |
| Registry record updated | August 28, 2026 |
| Trial ID | NCT06849570 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with invasive ventilation for ARDS in the ICU meeting Berlin criteria and hypoxemia thresholds, within specified time windows for randomizations.
✕Probably not a fit
Patients unlikely to benefit may include those without recruitable lung or those intolerant to prone positioning or neuromuscular blockade.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This master protocol investigates personalized strategies for mechanical ventilation in moderate-to-severe ARDS. It includes approaches to set PEEP based on individual recruitability and explores the role of prone positioning and neuromuscular blockade. The study uses a sequential randomization design to test minimal distension versus maximal recruitment strategies, combined with prone positioning and early or rescue neuromuscular blockade. Outcomes focus on whether patient-specific ventilation settings can improve oxygenation and survival while maintaining safety. The trial is conducted in French ICU centers under a centralized lead sponsor.
Why it matters
Potential benefit: If successful, patients may experience better oxygenation and potentially improved survival through more personalized ventilation and positioning strategies.
How similar studies have gone: Previous ARDS ventilation studies support low tidal volumes; this trial tests a novel, personalized PEEP and positioning approach, which is exploratory but builds on established principles.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Invasive mechanical ventilation within 96 hours of ICU admission and within 72 hours of tracheal intubation for first randomization and then within 72 hours of the first randomization for the second randomization * Patients meeting the Berlin ARDS definition criteria with hypoxemia characterized as * for first randomization: PaO2/FiO2 ≤150 mmHg on a PEEP ≥5 cmH2O with FiO2≥0.6 while VT is 6 ml/kg Predicted Body Weight (PBW) and adequate sedation level to adjust mechanical ventilation settings * for second randomization: PaO2/FiO2 ≤150 mmHg on optimized ventilatory settings according to the first randomization, confirmed by two Arterial blood gas (ABG) analyses separated by an interval time of 4 hours and observed within 72 hours of the first randomization * Informed consent signed: * by the patient * Or informed consent signed by a family members/trustworthy person if his condition does not allow him to express his consent by written as per L. 1111-6 * Or in a situation urgently and in the absence of family members/trustworthy person, the patient can be enrolled. The consent to participate to the research will be requested as soon as the condition of the patient will allow him to consent. * Health insurance coverage Exclusion Criteria: * Age \< 18 years * Known pregnancy or breastfeeding * Participation in another interventional studies as long as these studies do not interfere with the primary endpoint and the secondary safety objectives of PEPER, or being in the exclusion period at the end of a previous study. * Intracranial pressure \> 30 mm Hg or cerebral perfusion pressure \< 60 mmHg * Severe chronic respiratory disease requiring long-term O2 therapy or home mechanical ventilation (except Continuous positive arway pressure (CPAP)/ Bilevel positive airway pressure (BIPAP) used for sleep apnea syndrome) * Chronic interstitial lung disease * Continuous neuromuscular blockade infusion at enrolment * Previous hypersensitivity or anaphylactic reaction to any NMBA * Neuromuscular disease that may potentiate neuromuscular blockade or impair spontaneous ventilation: amyotrophic lateral sclerosis, Guillain-Barré syndrome, myasthenia gravis, upper spinal injury at level C5 or above * Patients on ECMO or any technique of extracorporeal CO2 removal * Sickle cell disease * Actual body weight \>1 kg/cm of height * Severe chronic liver disease defined as a Child-Pugh score of 12-15 * Pneumothorax at randomization * Expected duration of mechanical ventilation \<48 hours * Simplified acute physiology score SAPS II score \>75 at the time of enrolment or suffering from a disease with an estimated survival time of less than two months * Decision to withhold life-sustaining treatment * Patients deprived of freedom or under legal authority * Unstable spine fracture
Where it's running
-
CH Aix
Aix-en-Provence, France Recruiting -
Hôpital Pellegrin
Bordeaux, France Recruiting -
CH Fleyriat
Bourg-en-Bresse, France Recruiting -
Cavale Blanche
Brest, France Recruiting -
CHU de Caen Normandie
Caen, France Recruiting -
Hôpital de Dieppe
Dieppe, France Recruiting
Show 23 more locations
-
CHI Fréjus Saint Raphaël
Fréjus, France Recruiting -
Hôpital Raymond Poincaré AP-HP
Garches, France Recruiting -
CHU Grenoble
Grenoble, France Recruiting -
CH de Bicêtre
Le Kremlin-Bicêtre, France Recruiting -
CH du Mans
Le Mans, France Recruiting -
Croix Rousse
Lyon, France Recruiting -
Groupement Hospitalier Sud
Lyon, France Recruiting -
Hôpital Sait Joseph Saint Luc
Lyon, France Recruiting -
APHM CHU Nord
Marseille, France Recruiting -
La Timone
Marseille, France Recruiting -
Hôpital de Brabois
Nancy, France Recruiting -
CHU de Nantes
Nantes, France Recruiting -
Hopital de l'Archet 1
Nice, France Recruiting -
Hôpital Cochin AP-HP
Paris, France Recruiting -
Hôpital de La Pitié Salpetrière AP-HP
Paris, France Recruiting -
Hôpital Saint Louis
Paris, France Recruiting -
La Pitié Salpetriere hospital - AP-HP
Paris, France Recruiting -
Hôpital Charles Nicolle
Rouen, France Recruiting -
Hôpital Nord
Saint-Etienne, France Recruiting -
CMC Foch
Suresnes, France Recruiting -
Hôpital Bretonneau
Tours, France Recruiting -
Centre Hospitalier de Troyes
Troyes, France Recruiting -
Hôpital André Mignot
Versailles, France Recruiting
Study contacts
- Study coordinator: Alexandre Demoule, MD PhD
- Email: alexandre.demoule@aphp.fr
- Phone: +33 1 42 16 38 31
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding immune patterns and ECMO strategies to help adults with severe ARDS
This study tests how different immune and clinical patterns in adults with moderate-to-severe ARDS respond to ECMO and lung-protective care, aiming to improve outcomes.
-
Optimal corticosteroid dosing for ARDS: short vs. prolonged therapy
This trial tests different corticosteroid doses and treatment lengths to see which helps adults with ARDS who are on ventilators.
-
Lateral positioning to optimize breathing in adults after abdominal surgery with ARDS
This study tests whether lying on the left or right side helps improve lung function in adults who developed ARDS after abdominal surgery, using a bedside imaging test to watch ventilation and blood flow while changing positions.
-
Dexamethasone for sepsis-related ARDS in adults on ventilatory support
This trial tests whether dexamethasone can help adults with sepsis-associated ARDS on ventilators recover better compared to placebo.
-
NIRS for EDResp: Which first helps hypoxemic adults best?
This trial tests whether non-invasive ventilation with a mask (NIPPV) or high-flow nasal oxygen (HFNO) is more helpful for adults in the emergency department with acute hypoxemic respiratory failure.
-
Sodium bicarbonate with bedside electrical impedance tomography to map lung blood flow in ventilated adults
This project will try whether a small sodium bicarbonate injection combined with bedside electrical impedance tomography can map lung blood flow in adults on mechanical ventilation, compared with hypertonic saline.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.